IMS Health to Deliver Keynote Address on Orchestrated Customer Engagement at eyeforpharma Barcelona 2016

IMS Health Chief Digital Officer Richie Etwaru will deliver a keynote address on the opening day of eyeforpharma Barcelona, underscoring the critical role of end-to-end healthcare stakeholder engagement in driving better patient outcomes. The 14th annual eyeforpharma Barcelona conference, to be held March 15-17, is the world’s leading commercial and patient-centric pharma event—bringing together industry leaders in commercial excellence, patient engagement and innovation.

Etwaru’s address, Orchestrated Customer Engagement for Better Outcomes, will begin at 11:50 a.m. CET on Tuesday, March 15 in the Main Room of the Centre Convencions Internacional Barcelona. The presentation will highlight the industry and technology transformation underway that can lead to greater sales and marketing precision and place patient outcomes at the core of commercial operations. An IMS Health white paper on the topic, Orchestrated Customer Engagement: Orchestrate Every Customer Experience to Drive Results, also is available.

Additionally, IMS Health will host presentations and workshops during the eyeforpharma conference on multichannel marketing, sales excellence, data analytics and patient centricity. Visit the company’s exhibit area (#41 – 46) for more information.

About IMS Health

IMS Health (NYSE:IMS) is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160314005622/en/

IMS HealthTor Constantino, +1 [e-mail]